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Background: There are more and more women with recurrent spontaneous abortion (RSA). The mechanism of RSA
is still unclear. Immunological factors have been postulated to play a role in the etiology of RSA. Dendritic cells
(DCs) are the most potent antigen-presenting cells in the immune system, and the decidual DCs may take part in
the occurrence of RSA. The difference in maturity status of decidual DCs among women with RSA and women with
normal pregnancies is worthy of studying for its application to prevention and therapy.
Methods: The EnVision two-step immunohistochemical staining technique was used to detect the expression of
CD83 and CD1a in the decidua of women with RSA (30 cases) and normal pregnancies (30 cases). The maturity
status, distribution and quantity of DCs in the two groups were observed. Observation of the staining and cell
counting were done using microscope within 30 randomly selected high-power fields (HPF, 40 × 10). All data
analyses were conducted with SPSS 17.0 and the statistical significance was set at P <0.05.
Results: The decidua from the two groups contained DCs that stained with the anti-CD83 and anti-CD1a antibody.
Most of the decidual CD83+DCs from two groups were located in the stroma. There were more CD83+DCs clustered
with other DCs in the stroma from women with RSA than normal pregnancies. Most of the CD1a+DCs in the
decidua from the two groups are located close to maternal glandular epithelium. No difference in the location of
CD1a+DCs was found in the decidua between two groups. The number of decidual CD83+DCs was statistically
significantly higher in RSA women than in normal early pregnant women (14.20 ± 13.34/30 HPF versus 4.77 ± 2.64/30
HPF; t = 3.800, P = 0.001). The number of CD1a+DCs in the decidua was statistically significantly lower in RSA women
compared with normal early pregnant women (3.97 ± 3.75/30 HPF versus 7.60 ± 6.08/30 HPF; t = 2.786, P = 0.008).
Conclusions: These findings suggest that the increase in the number of mature DCs and the decrease in the quantity
of immature DCs in the decidua may be related to RSA. The maturation of decidual DCs may play an important role in
the pathogenesis of RSA.
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Miscarriage is the most common complication of preg-
nancy. Recurrent spontaneous abortion (RSA) is defined
as the miscarriage of three or more consecutive pregnan-
cies before 20 weeks of gestation and affects about 1% of
infertile couples [1]. Pregnancy is a phenomenon of* Correspondence: fbzhuxiaoming@163.com
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unless otherwise stated.successful semi-allograft. Its success depends on the
mother's immune tolerance of pregnancy. Pathological
pregnancy may occur if this tolerance is damaged. The
incidence of RSA is influenced by a number of pregnancy-
related factors, including anatomic, infectious, endocrine,
environmental, genetic and immunologic factors. Immuno-
logical factors have been postulated to play a role in the
etiology of recurrent miscarriage as the fetus and placenta
is semi-allogenic to the mother. Study in the CBA/J ×DBA/
2 J mouse model showed that the use of syngeneic DC
prevented abortions [2]. There has been a growing interesthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and fetal immune cells come into direct contact in
the decidua, which plays a key role in fetal tolerance.
Abnormal immune tolerance of maternal-fetal interface of
RSA is related to the dysregulation of human leukocyte
antigen (HLA) and apoptosis of natural killer (NK) cells, T
lymphocytes, macrophages, dendritic cells (DCs), and
other immune cells [3,4].
DCs are the most potent antigen-presenting cells
(APC) in the immune system with the unique ability to
induce primary immune responses [5]. DCs play an
important role in the initiation and regulation of immune
responses by regulating T cell-mediated immunity [6,7].
DCs also play an important role in inducing immune
tolerance [8]. DCs are derived from bone marrow
stem cells, migrate through the blood, and then disperse
widely in lymphoid tissues and nonlymphoid tissues, such
as liver, heart, kidney and lung tissue (except brain). There
are two entities of DCs that differ phenotypically and
functionally, the mature and immature DCs (mDCs and
iDCs) [7,9]. The iDCs are excellent at antigen uptake, but
are poor antigen presenters, and the reverse is true for the
mature subgroup. The iDCs transform into mDCs and
induce immune response under the influence of mature-
signals [7,10]. The differing character in the two groups of
DCs is the accessory molecule expression that can be
studied immunohistochemically. CD83 is a marker of
mDCs [11], and CD1a is a marker of iDCs [12].
DCs exist in normal endometrium and pregnancy
decidua [10,13]. Uterine DCs in the decidua have
been implicated in pregnancy maintenance. In early
pregnancy, PGE2 and IL-10 in the decidua can lead
to the generation of tolerant DCs [14,15]. The level
of IL-10 in placental tissue gradually increased with
the development of normal pregnancy, and high con-
centrations of IL-10 may inhibit the ability of DCs to
produce IL-12, and the balance of the T-helper-1 type
response/T-helper-2 type response (Th1/Th2) is shifted to
the Th2 direction. The iDCs in the decidua of a normal
pregnancy do not express CD83 molecules [16]. This
suggests that the formation of maternal-fetal immune
tolerance may be related to the immature status of
DCs in the microenvironment of the maternal-fetal
interface. Blois et al. [2] studied the effect of adoptive
transfer of DCs on the maintenance of pregnancy in
the CBA/J ×DBA/2 J mouse model. They found that
the control (no treatment) abortion rate was 23.8%,
and with GM-CSF alone was 17.6%. The abortion rate
was reduced to 2.2% after inoculation of syngeneic DCs. It
suggested that syngeneic DCs may have a significant
protective effect in miscarriage in pregnant mice. DCs
may not only have mediated the defensive immune
response, but also the tolerance of embryos. There
was a fine balance in the interaction between DCsand trophoblast cells during successful pregnancy in mice.
DCs therapy could upregulate a regulatory/protective
population of cells at the maternal-fetal interface [17,18].
Askelund et al. [19] found there were significantly more
CD83+DCs in the decidua from women with RSA than
normal pregnancies at 8 weeks’ gestation. It suggested that
DCs may be associated with any immune-related patho-
logical pregnancy, and DCs may play an important role in
the pathogenesis of RSA. However, little is known about
the underlying mechanisms. The difference in maturity
status of decidual DCs between women with RSA and
normal pregnancies is worthy of studying for its applica-
tion to prevention and therapy. This study examines the




This is a prospective study of DCs in the uterine decidua.
The specimens were obtained from the Department of
Obstetrics and Gynecology, Women’s Hospital, School of
Medicine, Zhejiang University, China. Samples of RSA
group (30 cases) were collected from women with RSA
by ultrasound guided curettage immediately upon con-
firmation of embryonic demise. Time delay between
embryonic demise and curettage was no more than 2 days.
Samples of the control group (30 cases) were collected
from women who underwent elective termination of
normal pregnancies without history of miscarriages in the
same hospital. All women were from 20 to 40 years
of age with gestation of less than 14 weeks. There
was no significant difference between the general infor-
mation of the two groups (Table 1). Excluded from the
study were women with genetic, endocrine and immune
disorders, cancer, genital anatomical abnormalities and
major surgical diseases, history of long-term medi-
cation, trophoblastic disease and those undergoing
endocrine therapy, chemotherapy, and radiotherapy. The
products of conception and the parents were karyotyped
to exclude chromosomal abnormalities in the RSA group.
Written informed consent was obtained from each patient
and the study was approved by the Institutional
Review Board of Women’s Hospital, School of Medicine,
Zhejiang University, China.
Immunohistochemistry
Decidua were immediately placed into a 10% formaldehyde
solution bag and fixed for 10 to 24 hours. Paraffin
blocks were sectioned into a 4-μm thickness. The EnVision
two-step immunohistochemical staining technique was
used to detect the expression of CD83 and CD1a in the
decidua. The immunohistochemical staining was done by
one person only. Positive controls were included in every
batch of tests. Primary antibodies: Mouse antihuman
Table 1 General information for the two groups
N Age (years; mean ± SD) Gestational age (days; mean ± SD) Abortions (mean ± SD)
RSA 30 29.77 ± 4.45 64.17 ± 11.36 4.33 ± 1.52
Normal pregnancy 30 28.87 ± 5.84 59.03 ± 9.35 3.93 ± 0.52
P 0.504 0.073 0.180
There was no significant difference between the general information for the two groups. RSA, recurrent spontaneous abortion.
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obtained from Novocastra Biotechnology Co., Ltd, US.
Mouse antihuman CD1a (Model GM357104, clone number
010) was obtained from DAKO Biotechnology Co., Ltd,
Denmark. The secondary antibody used was ChemMatei
Envisioni Detection Kit Peroxidase/DAB, from DAKO
Biotechnology Co., Ltd, Denmark. The normal tonsil was
used as a CD83 positive control, and the normal skin was
used as a CD1a positive control.
Dendritic cell counts
DCs displayed membrane staining, cytoplasmic staining,
and branch-like morphological features. MDCs were
characterized by the expression of CD83, and iDCs were
characterized by the expression of CD1a. The location
and number of DCs in the two groups were observed
within 30 randomly selected high-power fields (HPF, ×40
objective and × 10 eye piece). Observation of the staining
and cell counting were done using a Olympus CHK
microscope (Olympus, Japan). Photomicrographs were
taken using a digital camera (Nikon, Japan). All the
immunostained slides were reviewed by two observers
independently.
Statistics
The difference in the counts of DCs between the two
groups was evaluated. All data analyses were conducted
with SPSS 17.0 (SPSS Inc., USA). Statistical significance
was set at P <0.05, and P values from all tests were
reported. The statistical significance of the experimen-
tal differences in the two groups was assessed by a
normal distribution test first. If the data were normally
distributed, an independent samples t test for continuous
variables analysis was used, and if the data were not nor-
mally distributed, a non-parametric test (Mann-Whitney
Test) was used.
Results
The location of decidual dendritic cells
CD83+ DCs were found in decidual samples from both
RSA and normal pregnancies. DCs displayed membrane
staining, cytoplasmic staining, and appropriate morpho-
logical features. Most of the CD83+DCs in the decidua
from women with RSA were clustered with other DCs
(Figure 1A), and few of them were present as single cells in
the stroma. The localization of CD83+DCs in the deciduaof women with normal pregnancies was similar to that
seen for women with RSA. However, most of the decidual
CD83+DCs from women with normal pregnancies were
present as single cells in the stroma and were not clustered
with other DCs (Figure 1B). Very few of CD83+DCs were
located close to maternal glandular epithelium. The
decidua from all groups were found to contain DCs that
stained with the anti-CD1a antibody. CD1a+ DCs displayed
membrane staining, cytoplasmic staining, and branch-like
morphological features. Most of the decidual CD1a+DCs in
the two groups were located close to maternal glandular
epithelium and uterine epithelium (Figure 2A, B). There
was no difference in the location of CD1a+ DCs in the
decidua between the two groups.
Dendritic cell counts
The number of CD83+DCs of decidual tissue from
women with RSA was 14.20 ± 13.34/30 HPF and from
women with normal pregnancies was 4.77 ± 2.64/30
HPF. There were significantly more CD83+DCs in the
decidua of women with RSA than in women with
normal pregnancies (t = 3.800, P = 0.001). The number of
decidual CD1a+ DCs in RSA and normal pregnancies
groups were 3.97 ± 3.75/30HPF and 7.60 ± 6.08/30HPF,
respectively. There were more CD1a+DCs in the decidua
from normal pregnancies than RSA, and the difference
was significant (t = 2.786, P = 0.008) .
Discussion
The maternal-fetal relationship is a unique immunologic
phenomenon. Our research revealed that most of the
mDCs in the decidua from the two groups were located
in the stroma. There were more CD83+DCs clustered
with other DCs in the stroma from women with RSA
than from women with normal pregnancies. CD83+DCs’
aggregate suggests that these DCs may be immunologically
active. Our results were somewhat different from the
results of others. Askelund et al. [19] reported that most of
the CD83+DCs in the decidua from women with RSA and
normal pregnancies were present as single cells in the
stroma. It might be that many of the DCs distributed
randomly throughout the decidual stroma were also in
close proximity to T cells so they might also be immuno-
logically active. The difference may be due to the different
maturation status of DCs and the small number of decid-
ual samples in both studies. Kammerer et al. [20] found
Figure 1 CD83+ dendritic cells (DCs) in the decidua of the two groups. (A) Decidua of recurrent spontaneous abortion (RSA) (a few of CD83
+DCs clustered in the stroma, 40 × 10). (B) Decidua of normal pregnancies (a single CD83+DC in the stroma, with membrane staining, cytoplasmic
staining and branch-like morphology, 40 × 10).
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decidua in normal early pregnancies. It may be due to our
decidual samplings, which were more superficial. It is also
possible that the different distribution of DCs throughout
the decidua may represent the early stages of a maternal
immune response to the failed pregnancy, rather than a
cause of pregnancy failure. However, this seems unlikely as
the time delay between embryonic demise and curettage
was no more than 2 days in our study.
CD1a+ DCs were found in both decidual samples of
RSA and normal pregnancies. Most of the decidual
CD1a+DCs in two groups were located close to maternal
glandular epithelium or uterine epithelium and there
was no difference between two groups. There wereFigure 2 CD1a+ dendritic cells (DCs) in the decidua of the two groups
+DCs were located close to uterine epithelium, 40 × 10). (B) Decidua of nor
epithelium, with membrane staining, cytoplasmic staining and branch-likesome discrepancies between our data and those from
Gardner et al. [13], who reported an absence of CD1a
expression in decidual leukocytes and no cells in the
stroma stained for CD1a at 7 to 12 weeks gestation. The
difference between our results and those of Gardner et al.
may be due to the different experimental method
(immunofluorescence labeling for flow cytometry) used by
Gardner et al. We consider that the glandular epithelium
and uterine epithelium are the primary position of the
local maternal-fetal immune response. Maternal glandular
epithelium is close to gestational sac (the maternal-fetal
interface). DCs and other immune cells may be involved
in gathering the local immune response in the uterine
decidua during the embryo’s implantation.. (A) Decidua of recurrent spontaneous abortion (RSA) (some CD1a
mal pregnancies (a few of CD1a+DCs were located close to glandular
morphology, 40 × 10).
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CD83+DCs population in RSA was higher than the mean
population in the normal pregnancies and was statisti-
cally significant. This observation suggests the increase
in the number of mDCs probably related to the patho-
genesis of RSA. This is different to the findings by
Askelund et al. [19]. They did not find significant differ-
ences in DCs numbers between the women with recur-
rent miscarriage and women with normal pregnancies.
We assume that an active immune response exists in the
RSA decidua. The maturation of DCs determines the
outcome of immune response. IDCs can lead to immune
tolerance in the physiological condition and require a
maturation step that promotes antigen presentation to
prime the T cell activity and trigger the immune response.
IDCs transform into mDCs and induce immune response
under the influence of mature-signals (such as bacterial
DNA, proinflammatory cytokines, etc.). DCs initiate the
function of T cell strongly at this time.
DCs are responsible for stimulating virgin T cells, a
property that distinguishes them from other APC. The
action of cytotoxic T cells in large part determines
whether an allograft survives or is rejected. DCs are
involved in regulating the balance between Th1 and
Th2, and the Th1/Th2 balance regulates the maintenance
of the pregnancy. The maternal balance between Th1 and
Th2 type cytokines contributes to the success of the
pregnancy [21,22]. Th1-type cytokines (such as IL-2,
IL-12, IFN-γ, TNF-β, etc.) can defend against microbial
infections, and also may lead to abortion. For example,
IL-12 can promote a T cell to Th1-type biased, induced
immune response. However, Th2-type cytokines (such as
IL-4, IL-5, IL-10, etc.) can lead to less autoimmunity,
susceptible to infections, and also may induce pregnancy-
tolerance to fetus, providing protection to pregnancy. For
instance, IL-10 can induce T-cell regulation (regulatory T
cells, Treg) and promote monocyte-derived DCs induce
antigen-specific CD4+ and CD8+ T cell immune incompe-
tence [23], which can inhibit immune response of T-cell
and induce tolerance of T cell [24].
Research on mouse models [25] showed that fetal
antigens on the placenta during the implant period
could stimulate DCs in the decidua to produce Th1-type
cytokines. Th2-type cytokines then dominated. The level of
IL-10 in placenta gradually increased with the development
of pregnancy in normal pregnancy. High concentrations of
IL-10 may inhibit the decidual DCs' ability to produce
IL-12 and then regulates the Th1/Th2 balance to Th2
and shift the direction of the end-mediated immune
tolerance to the fetus. Decidual iDCs uptake antigens
and then transform into mDCs with antigen presenting
function, which can induce and stimulate the proliferation
of naive T cells. The maternal immune response breaks
the balance between Th1/Th2, and makes the maternalimmune response to Th1-type. The above reaction leads
to a semi-allograft immune response to the fetal and
placenta by mother and occurrence of miscarriage
eventually.
IDCs are characterized by the CD1a expression. We
found lesser CD1a+DCs in the decidua of RSA than in
the decidua from normal pregnancies. This suggests that
the decrease in the quantity of iDCs is probably related
to the occurrence of RSA. It is possible that decidual
iDCs play a role in the maintenance of normal preg-
nancy through the regulation of maternal-fetal immune
tolerance [26]. Most of the DCs in the nonlymphoid
organs are immature. Studies found that some DCs
subtypes in human decidua may play an important role
to maintain pregnancy [27,28]. Decidual DCs may have
a significant protective effect in miscarriage in pregnant
mice [2]. Therapy with DCs can reduce the spontaneous
abortion rate, through a mechanism whereby DCs
therapy differentially upregulated a regulatory/protective
population of cells at the fetal-maternal interface [18].
DCs may regulate the Treg cells to suppress the semi-
allograft rejection from mother to the fetus and play an
important role in the maternal-fetal immune tolerance.
Treg cells have significant roles in the negative regula-
tion of immune response and induction of immune
tolerance. CD4+CD25+ Treg cells exist in both maternal
blood and decidua throughout pregnancy. Zenclussen et al.
[29] reported Treg cells were proposed to play an
essential role. Normal pregnant mice show an expansion
of CD4+CD25+ and IL-10+ Treg cells at the periphery com-
pared to nonpregnant animals. Further, they suggested sig-
nificantly lower frequencies of Treg cells in abortion-prone
mice. CD4+CD25+ Treg cells from normal pregnant mice
were able to prevent fetal rejection. Accordingly, downregu-
lated levels of Treg cells were also reported during human
miscarriage. There was an increase in circulating Treg
cells during early pregnancy, peaking during the
second-trimester [30]. In peripheral blood, statistically
significantly higher proportions of CD4+CD25+T cells
expression was observed in normal early pregnant
women compared with normal nonpregnant women
and unexplained RSA patients. There were statistically
significantly lower proportions of CD4+CD25+ T cells
expression in unexplained RSA patients compared with
normal early pregnant women in their decidua [31].
IDCs inhibit proliferation of antigen-specific T cell by
self-secretion of IL-10. IDCs induce CD4+CD25+ Treg
and CD8+ suppressor T cells, which inhibit the immune
response [32]. IL-10 secreted by DCs was increased
when there is interaction between DCs and Treg cells.
DCs and Treg cells formed a feedback inhibition [33].
IDCs in the peripheral tissue induce removal of antigen-
specific T cells and induce peripheral tolerance under
normal physiological conditions without infection and
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‘danger signals’ from tissue damage to maintain tolerance
of self-antigens and harmless exogenous antigens through
this mechanism.
Conclusions
In spite of an increasing interest, the etiology of RSA re-
mains unknown in approximately 50 percent of cases.
This study demonstrates significant associations between
the maturation of decidual DCs and RSA. The increase
in the number of mDCs and the decrease in the number
of iDCs may be related to RSA. As mDCs are important
antigen presenters, these observations suggest the existence
of an active immune response in the decidua of women
with RSA. DCs play an important role in the aetiology of
RSA. However, its specific pathogenesis has not been clari-
fied exactly yet, and the immunologic nature of RSA has
generated considerable interest and controversy. Many
factors could be correlated to RSA. For example, passive
smoking, a higher body mass index (BMI), and a family
history of RSA were thought to be independent risk factors
for RSA [34]. Further researches are needed to characterize
the specific functions of decidual DCs. Despite aware-
ness of the limitations of this study due to the small
sample size and semi-quantitative evaluation, the results
encourage further larger studies in this promising
research field.
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